Loading company…
Leuven-based miDiagnostics NV develops silicon chip-based point-of-care test cards for ultrafast PCR testing.
Founded in 2015 and headquartered in Leuven, Belgium, miDiagnostics NV develops diagnostic testing solutions built on proprietary silicon chip technology. Its test card supports ultrafast PCR testing at the point of care, for settings such as nursing homes and home care, and it sells to healthcare providers and bio-pharma firms in Europe and the United States. In December 2024 it raised EUR 30.00 mn in Series D funding led by Thermo Fisher Scientific Inc., with participation from Alychlo, Pamica and VMF Invest.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in